SCHEMBL2721139

SCHEMBL2721139

CC(=O)Oc1ccc(C23CC4CC(CC(C4)C2)C3)cc1

nearest known ligand 0.59

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.59
MEN1 O00255 3/20 0.59
KMT2A Q03164 3/20 0.59
RAB9A P51151 1/20 0.59
EPHX2 P34913 3/20 0.55
LMNA P02545 6/20 0.50
ALDH1A1 P00352 2/20 0.50
CASP2 P42575 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
MAPT P10636 3/20 0.46
HIF1A Q16665 3/20 0.46
GAA P10253 2/20 0.46
XBP1 P17861 1/20 0.46
POLB P06746 3/20 0.46
GFER P55789 1/20 0.46
EPAS1 Q99814 2/20 0.45
PKM P14618 1/20 0.44
TP53 P04637 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL822923 0.85 LMNA (0.57) NPC1MEN1KMT2ARAB9AEPHX2
SCHEMBL28686352 0.83 MEN1 (0.68) NPC1MEN1KMT2ARAB9AEPHX2
SCHEMBL11705372 0.82 NPC1 (0.51) NPC1MEN1KMT2ARAB9AEPHX2
SCHEMBL11705383 0.82 NPC1 (0.51) NPC1MEN1KMT2ARAB9AEPHX2
SCHEMBL16158225 0.81 MEN1 (0.74) NPC1MEN1KMT2ARAB9ALMNA
SCHEMBL12746127 0.80 NPC1 (0.52) NPC1MEN1KMT2ARAB9AEPHX2
SCHEMBL12128714 0.80 MEN1 (0.52) NPC1MEN1KMT2ARAB9AEPHX2
SCHEMBL28601819 0.79 NPC1 (0.63) NPC1MEN1KMT2ARAB9AEPHX2
SCHEMBL12745789 0.79 NPC1 (0.51) NPC1MEN1KMT2ARAB9AEPHX2
SCHEMBL12040557 0.78 LMNA (0.57) NPC1MEN1KMT2ARAB9AEPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180356421-A9 Small-Molecule Hydrophobic Tagging of Fusion Proteins and Induced Degradation of Same UNIV YALE (US) 2018-12-13 US disclosed
US-10145848-B2 Small-molecule hydrophobic tagging of fusion proteins and induced degradation of same YALE UNIVERSITY (US) 2018-12-04 US disclosed
US-20170307614-A1 Small-Molecule Hydrophobic Tagging of Fusion Proteins and Induced Degradation of Same UNIV YALE (US) 2017-10-26 US disclosed
US-20170239259-A1 ARYLOXY PHENOXY ACRYLIC COMPOUND HAVING HIF-1 INHIBITION ACTIVITY, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME AS AN ACTIVE INGREDIENT KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) 2017-08-24 US disclosed
US-9632089-B2 Small-molecule hydrophobic tagging of fusion proteins and induced degradation of same YALE UNIVERSITY (US) 2017-04-25 US disclosed
US-20170067874-A1 Small-Molecule Hydrophobic Tagging of Fusion Proteins and Induced Degradation of Same NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2017-03-09 US disclosed
US-9500653-B2 Small-molecule hydrophobic tagging of fusion proteins and induced degradation of same YALE UNIVERSITY (US) 2016-11-22 US disclosed
US-8940936-B2 Aryloxy phenoxy acrylic compound having HIF-1 inhibition activity, method for preparing same, and pharmaceutical composition containing same as an active ingredient KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) 2015-01-27 US disclosed
US-20140302523-A1 Small-Molecule Hydrophobic Tagging of Fusion Proteins and Induced Degradation of Same YALE UNIVERSITY (US) 2014-10-09 US disclosed
EP-2649099-A2 SMALL-MOLECULE HYDROPHOBIC TAGGING OF FUSION PROTEINS AND INDUCED DEGRADATION OF SAME Yale University (US) 2013-10-16 EP disclosed
US-20130237542-A1 ARYLOXY PHENOXY ACRYLIC COMPOUND HAVING HIF-1 INHIBITION ACTIVITY, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME AS AN ACTIVE INGREDIENT DONGGUK UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION (KR) 2013-09-12 US disclosed
US-8394799-B2 Compounds that inhibit HIF-1 activity, the method for preparation thereof and the pharmaceutical composition containing them as an effective component KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) 2013-03-12 US disclosed
WO-2012078559-A2 SMALL-MOLECULE HYDROPHOBIC TAGGING OF FUSION PROTEINS AND INDUCED DEGRADATION OF SAME YALE UNIVERSITY (US) 2012-06-14 WO disclosed
WO-2012053768-A2 ARYLOXYPHENOXYACETYL-BASED COMPOUND HAVING HIF-1 INHIBITION ACTIVITY, PREPARATION METHOD THEREOF AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME AS AN ACTIVE INGREDIENT KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) 2012-04-26 WO disclosed
US-20090306078-A1 COMPOUNDS THAT INHIBIT HIF-1 ACTIVITY, THE METHOD FOR PREPARATION THEREOF AND THE PHARMACEUTICAL COMPOSITION CONTAINING THEM AS AN EFFECTIVE COMPONENT KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) 2009-12-10 US disclosed
WO-2008004798-A1 COMPOUNDS THAT INHIBIT HIF-1 ACTIVITY, THE METHOD FOR PREPARATION THEREOF AND THE PHARMACEUTICAL COMPOSITION CONTAINING THEM AS AN EFFECTIVE COMPONENT KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) 2008-01-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180356421-A9 Small-Molecule Hydrophobic Tagging of Fusion Proteins and Induced Degradation of Same HSP90B1, LAMP2, PSMG3 NPC1 370/4885MEN1 2899/4885KMT2A 3767/4885
US-10145848-B2 Small-molecule hydrophobic tagging of fusion proteins and induced degradation of same HSP90B1, LAMP2, PSMG3 NPC1 370/4885MEN1 2899/4885KMT2A 3767/4885
US-20090306078-A1 COMPOUNDS THAT INHIBIT HIF-1 ACTIVITY, THE METHOD FOR PREPARATION THEREOF AND THE PHARMACEUTICAL COMPOSITION CONTAINING THEM AS AN EFFECTIVE COMPONENT HIF1AN, HIF1A, VHL NPC1 1221/4885MEN1 3620/4885KMT2A 1390/4885
US-20170067874-A1 Small-Molecule Hydrophobic Tagging of Fusion Proteins and Induced Degradation of Same HSP90B1, LAMP2, PSMG3 NPC1 353/4885MEN1 2916/4885KMT2A 3792/4885
US-20130237542-A1 ARYLOXY PHENOXY ACRYLIC COMPOUND HAVING HIF-1 INHIBITION ACTIVITY, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME AS AN ACTIVE INGREDIENT HIF1A, HIF1AN, VHL NPC1 1454/4885MEN1 3882/4885KMT2A 628/4885
US-20170239259-A1 ARYLOXY PHENOXY ACRYLIC COMPOUND HAVING HIF-1 INHIBITION ACTIVITY, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME AS AN ACTIVE INGREDIENT HIF1A, HIF1AN, VHL NPC1 1454/4885MEN1 3882/4885KMT2A 628/4885
US-20170307614-A1 Small-Molecule Hydrophobic Tagging of Fusion Proteins and Induced Degradation of Same HSP90B1, LAMP2, PSMG3 NPC1 370/4885MEN1 2899/4885KMT2A 3767/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.